Share this Article
Jin AZ, Louange EC, Chow KY, Fock C
Correspondence: Dr Jin Ai Zhen, Jin_ Ai_ Zhen@hpb.gov.sg
ABSTRACT
Introduction A retrospective observational study was performed to evaluate the effectiveness of CervicalScreen Singapore (CSS), a National Cervical Cancer Screening Programmme.
Methods National trends on incidence, mortality of cervical cancer and carcinoma in situof the cervix before and after the launch of CSS were examined. Linear regression was used to calculate the average annual percentage change in age-standardised incidence and mortality rates. We also examined the operational measures of CSS, such as the women who joined the CSS programme and the diagnostic accuracy of Pap smears. The study was confined to women who consented to join CSS at government-funded polyclinics.
Results Nationally, there was a greater decline in the age-standardised incidence and mortality rates in the period 2004–2008 as compared to the period 1987–2003. Under CSS, a total of 99,759 Pap smears were performed on 81,087 women in the period 2004–2008. However, the number of first screens decreased from 18,434 in 2004 to 11,624 in 2008. Among women aged 25–69 years who had their first Pap smear screening and who were recommended for routine rescreen in three years, 10% had a subsequent rescreen within three years. Overall, the CSS programme was able to detect 0.37 invasive cancers per 1,000 screens in women aged 25–69 years.
Conclusion The CSS programme has contributed to a decline in the mortality and incidence of cervical cancer in Singapore. However, the challenges of increasing the screening uptake among eligible women need to be addressed.
Keywords: cervical cancer screening, effectiveness, evaluation
Singapore Med J 2013; 54(2): 96–101; http://dx.doi.org/10.11622/smedj.2013032
REFERENCES
| 1. The Globocan Project 2008 [online]. Available at: globocan.iarc.fr/. Accessed August 22, 2012. | ||||
| 2. Ahmad OB, Boschi-Pinto C, Lopez A, et al. Age standardization of rates: a new WHO standard [online]. Available at: www.who.int/healthinfo/paper31.pdf. Accessed August 22, 2012. | ||||
| 3. Läärä E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programme. Lancet 1987; 1:1247-9. http://dx.doi.org/10.1016/S0140-6736(87)92695-X | ||||
| 4. Canfell K, Sitas F, Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust 2006; 185:482-6. | ||||
| 5. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention: Cervix Cancer Screening. Lyon: IARC Press, 2005. | ||||
| 6. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999; 318:904-8. http://dx.doi.org/10.1136/bmj.318.7188.904 | ||||
| 7. Ministry of Health, Singapore. National Health Survey 1998. | ||||
| 8. Ministry of Health, Singapore. National Health Surveillance Survey 2007. | ||||
| 9. Draeby-Kristiansen J, Garsaae M, Bruun M, Hansen K. Ten years after cryosurgical treatment of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1991; 165:43-5. | ||||
| 10. Andersen ES, Husth M. Cryosurgery for cervical intraepithelial neoplasia: 10-year follow-up. Gynecol Oncol 1992; 45:240-2. http://dx.doi.org/10.1016/0090-8258(92)90297-V | ||||
| 11. Ministry of Health. Communicable Diseases Surveillance in Singapore 2010. | ||||
| 12. Ministry of Health, Singapore. National Health Survey 2010. | ||||
| 13. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340:1144-53. http://dx.doi.org/10.1056/NEJM199904153401502 | ||||
| 14. Wong LP, Wong YL, Low WY, Khoo EM, Shuib R. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study. Singapore Med J 2009; 50:49-53. | ||||
| 15. Weller DP, Campbell C. Uptake in cancer screening programmes: a priority in cancer control. Br J Cancer 2009; 101:S55-9. http://dx.doi.org/10.1038/sj.bjc.6605391 | ||||
| 16. Fang CY, Ma GX, Tan Y, Chi N. A multifaceted intervention to increase cervical cancer screening among underserved Korean women. Cancer Epidemiol Biomarkers Prev 2007; 16:1298-302. http://dx.doi.org/10.1158/1055-9965.EPI-07-0091 | ||||
| 17. Meissner HI, Smith RA, Rimer BK, et al. Promoting cancer screening: learning from experience. Cancer 2004; 101(5 Suppl):1107-17. http://dx.doi.org/10.1002/cncr.20507 | ||||
| 18. Twinn SF, Holroyd E, Fabrizio C, et al. Increasing knowledge about and uptake of cervical cancer screening in Hong Kong Chinese women over 40 years. Hong Kong Med J 2007; 13:16-20. | ||||
| 19. Giordano L, Webster P, Anthony C, et al. Improving the quality of communication in organized cervical cancer screening programmes. Patient Educ Couns 2008; 72:130-6. http://dx.doi.org/10.1016/j.pec.2008.02.010 | ||||
| 20. Rahman S, Price JH, Dignan M, et al. Access to mammography facilities and detection of breast cancer by screening mammography: a GIS approach. Int J Canc Prev 2009; 2:403-13. | ||||
| 21. Goldhaber-Fiebert JD, Denny LE, De Souza M, et al. The costs of reducing loss to follow-up in South African cervical cancer screening. Cost Eff Resour Alloc 2005; 3:11. http://dx.doi.org/10.1186/1478-7547-3-11 | ||||
| 22. Simoes EJ, Newschaffer CJ, Hagdrup N, et al. Predictors of compliance with recommended cervical cancer screening schedule: a population-based study. J Community Health 1999; 24:115-30. http://dx.doi.org/10.1023/A:1018754307718 | ||||
| 23. Fernández-Esquer ME, Espinoza P, Ramirez AG, McAlister AL. Repeated Pap smear screening among Mexican-American women. Health Educ Res 2003; 18:477-87. http://dx.doi.org/10.1093/her/cyf037 | ||||
| 24. Goins KV, Zapka JG, Geiger AM, et al. Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations. Am J Manag Care 2003; 9:745-55. | ||||
| 25. Karani A, De Vuyst H, Luchters S, et al. The Pap smear for detection of bacterial vaginosis. Int J Gynaecol Obstet 2007; 98:20-3. http://dx.doi.org/10.1016/j.ijgo.2007.03.010 | ||||
| 26 .Specificity, sensitivity and cost. Nat Rev Cancer 2007; 7:893. doi: 10.1038/nrc2287. http://dx.doi.org/10.1038/nrc2287 | ||||
| 27. Anttila A, Ronco G, Clifford G,et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004 31; 91:935-41. | ||||
| 28. Davidson M, Bulkow LR, Lanier AP, et al. Incidence of invasive cervical cancer preceded by negative screening in high-risk Alaska Native women. Int J Epidemiol 1994; 23:238-45. http://dx.doi.org/10.1093/ije/23.2.238 | ||||